Marijuana CO Of America, Inc. MCOA
We take great care to ensure that the data presented and summarized in this overview for Marijuana Co of America, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MCOA
View allLatest Institutional Activity in MCOA
Top Purchases
Top Sells
About MCOA
Marijuana Company of America, Inc., together with its subsidiaries, develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand name in the United States. The company offers hempSMART products comprising hempSMART Brain, a patented and formulated personal care consumer product for brain wellness; hempSMART Pain capsules for temporary relief of minor discomfort with physical activity; hempSMART Pain Cream to reduce minor discomfort and promote muscle relaxation; hempSMART Drops, a hemp CBD oil tincture drops; hempSMART Pet Drops for cats and dogs; hempSMART Face, a facial moisturizer; and hempSMART drink mix, an industrial hemp based powderized CBD drink through its web site and affiliate marketing programs. It also distributes hemp and CBD products, such as smoke and vape shop related products to wholesalers, c-stores, specialty retailers, and consumers through www.cdistro.com. The company was formerly known as Converge Global, Inc. and changed its name to Marijuana Company of America, Inc. in December 2015. Marijuana Company of America, Inc. was incorporated in 1985 and is based in Los Angeles, California.
Insider Transactions at MCOA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 24
2021
|
Jesus Quintero CEO, CFO |
SELL
Open market or private sale
|
Direct |
3,966,666
-11.45%
|
-
|
Nov 23
2021
|
Jesus Quintero CEO, CFO |
SELL
Open market or private sale
|
Direct |
2,700,000
-7.23%
|
-
|
Sep 10
2021
|
Jesus Quintero CEO, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
26,315,789
+41.35%
|
-
|
Jan 25
2021
|
Themistocles Psomiadis Director |
SELL
Open market or private sale
|
Direct |
2,000,000
-16.66%
|
$0
$0.01 P/Share
|
Jan 20
2021
|
Themistocles Psomiadis Director |
SELL
Open market or private sale
|
Direct |
1,428,571
-12.5%
|
$0
$0.01 P/Share
|
Dec 04
2020
|
Themistocles Psomiadis Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,500,001
-10.05%
|
$0
$0.01 P/Share
|
Nov 25
2020
|
Themistocles Psomiadis Director |
BUY
Open market or private purchase
|
Direct |
11,428,571
+43.36%
|
-
|
Oct 05
2020
|
Themistocles Psomiadis Director |
BUY
Open market or private purchase
|
Direct |
1,500,001
+29.98%
|
-
|